LAROTRECTINIB Pharmacologic Class Indexing
- Class set ID
- 927cb6c6-bf71-4631-a7ee-a66f50897ee8
- Version
- 1
- Effective date
- 20200302
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use VITRAKVI safely and effectively. See full prescribing information for VITRAKVI. VITRAKVI ® (larotrectinib) capsules, for oral use VITRAKVI ® (larotrectinib) oral solution Initial U.S. Approval: 2018 | Bayer HealthCare Pharmaceuticals Inc. | 20260522 | 21 |
| These highlights do not include all the information needed to use VITRAKVI safely and effectively. See full prescribing information for VITRAKVI. VITRAKVI ® (larotrectinib) capsules, for oral use VITRAKVI ® (larotrectinib) oral solution Initial U.S. Approval: 2018 | Loxo Oncology, Inc. | Penn Pharmaceutical Services Ltd | Albemarle Corporation | Sharp Corporation | 20181205 | 3 |